We have progressed into a global organization and have evolved to become one of the most successful pharmaceutical companies across emerging markets over a short period of time.This is clearly reflected by our expanded wealth creation,
manufacturing footprint, international operations and global employee base. Our prudent strategic priorities have given us the impetus to become a leading research-driven, global, integrated pharmaceutical company.
With a present focus towards innovation and a robust growth framework, our drug discovery endeavors continue to play a vital role in the therapeutic areas of dermatology, respiratory and oncology. As we continue our journey, the determination to develop innovative molecules to address needs of patients and make a difference, remains our priority.
|